Metastatic Renal Cell Carcinoma: Updates to CheckMate 9ER and COSMIC-313 Trial Data

Rana McKay, MD presents an overview of metastatic/stage IV RCC, touching on incidence, the typical RCC patient she sees in her practice, and available first-line treatments for metastatic clear cell RCC.

Dr McKay reviews key trial data from the CheckMate 9ER trial including eligible patient populations, study design, and safety/efficacy data.

Discussion centered around the unmet needs that the COSMIC-313 trial aims to address, as well as information about included patient populations, study design, and recent conference data.

Rana McKay, MD closes by offering actionable advice for community oncologists and considers the potential clinical implications of these and other emerging data.